510(k) Report

510(k) · Cleared

Cleared

Tina-Quant Igg Gen.2

K050113510(k) TraditionalCleared Feb 8, 200521-day reviewClass II21 CFR 866.5510

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics Corp. · DEW Igg, Antigen, Antiserum, Control

Cleared on Feb 8, 2005 as substantially equivalent to K943997 (Behring Diagnostics, Inc., 1994) after a 21-day review. Its family tree reaches back 1 generation to 1994. 4 later devices descend from it.

Decided
Feb 8, 2005
Review
21 days
Class
Class II
Product code
DEW
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K943997 (1994). 4 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2008: 1 descendant cleared2017: 1 descendant cleared2020: 1 descendant cleared2023: 1 descendant clearedK943997 · Behring Nephelometer II · Behring Diagnostics, Inc. · 19941990200020102020
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 2 descendants3 generations forward: 1 descendant K943997 · Behring Nephelometer II · Behring Diagnostics, Inc. · 19940
  1. Root · 1 generation backK943997 Behring Nephelometer IIBehring Diagnostics, Inc. · 1994
  2. This deviceK050113 Tina-Quant Igg Gen.2Roche Diagnostics Corp. · 2005
  3. Descendant · cites it directly · 3 of its ownK073490 Olympus Igg ReagentOlympus America, Inc. · 2008
  4. Descendant · 2 generations on · 1 of its ownK162208 DxC 700 AU Clinical Chemistry Analyzer, AU IgG ReagentBeckman Coulter, Inc. · 2017
  5. Descendant · 3 generations on · 0 of its ownK221114 Immunoglobulin G (IgG)Beckman Coulter Laboratory Systems (Suzhou) Co., Ltd. · 2023
  6. Descendant · 2 generations on · 0 of its ownK193525 Yumizen C1200 Immunoglobulin A, Yumizen C1200 Immunoglobulin G…Horiba Abx Sas · 2020

Most influential descendants

Showing 4 of 4 · See all
  • K073490Olympus Igg ReagentOlympus America, Inc. · 2008 · cites it directly3descendants
  • K162208DxC 700 AU Clinical Chemistry Analyzer, AU IgG ReagentBeckman Coulter, Inc. · 2017 · 2 generations on1descendant
  • K221114Immunoglobulin G (IgG)Beckman Coulter Laboratory Systems (Suzhou) Co., Ltd. · 2023 · 3 generations on0descendants
  • K193525Yumizen C1200 Immunoglobulin A, Yumizen C1200 Immunoglobulin G, Yumizen C1200…Horiba Abx Sas · 2020 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K943997Behring Nephelometer IIBehring Diagnostics, Inc.1994—
0 (this device)K050113Tina-Quant Igg Gen.2Roche Diagnostics Corp.2005—
+1K073490Olympus Igg ReagentOlympus America, Inc.2008—
+2K162208DxC 700 AU Clinical Chemistry Analyzer, AU IgG ReagentBeckman Coulter, Inc.2017—
+3K221114Immunoglobulin G (IgG)Beckman Coulter Laboratory Systems (Suzhou) Co., Ltd.2023—
+2K193525Yumizen C1200 Immunoglobulin A, Yumizen C1200 Immunoglobulin G, Yumizen C1200…Horiba Abx Sas2020—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
201710
202010
202310
FIG. 1 — Lineage of K050113, 1994–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DEW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K943997Behring Nephelometer II
Summary page 5
…e claim equivalence to in Dade Behring N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) IgG assay on the BN I1 cleared under K943997. Both products are intended for use in the quantitative determination of IgG in human CSF. Substantial…
Behring Diagnostics, Inc.1994—

What descends from it? (4)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K073490Olympus Igg ReagentOlympus America, Inc.20083

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K073490 (Olympus America, Inc., 2008) has gone furthest, with 3 descendants of its own.

How does its category compare?

All DEW devices

DEW Igg, Antigen, Antiserum, Control: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DEW

FDA has decided no DEW device since 2007.

Median 510(k) review, days · DEW

Too few DEW 510(k)s in any year since 2007 to give a median.

Recalls per year · DEW

1in 2024

2010: 12024: 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DEW

4in 2024

2009: 42010: 22011: 162015: 22016: 42017: 62018: 12019: 92020: 192023: 12024: 4
2007high 19 (2020) · low 0 (2007)2025

MAUDE reports naming product code DEW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—04
20100—12
20110—016
20120—00
20130—00
20140—00
20150—02
20160—04
20170—06
20180—01
20190—09
20200—019
20210—00
20220—00
20230—01
20240—14
20250—00
20260—0—

What is it indicated for?

Immunoturbidimetric assay for the quantitative in vitro determination of IgG in human serum, plasma and cerebrospinal fluid (CSF) on Roche automated clinical chemistry analyzers.

Measurement of IgG aids in the diagnosis of abnormal protein metabolism and the body's lack of ability to resist infectious agents.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K050113: Tina-Quant Igg Gen.2.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K050113

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026